Literature DB >> 29917188

Mechanism of lncRNA DUXAP8 in promoting proliferation of bladder cancer cells by regulating PTEN.

M-G Lin1, Y-K Hong, Y Zhang, B-B Lin, X-J He.   

Abstract

OBJECTIVE: To evaluate the lncRNA DUXAP8 expression in bladder cancer and its mechanism. PATIENTS AND METHODS: Clinical specimens were analyzed. The expression of lncRNA in bladder cancer and adjacent tissues was detected using qRT-PCR. The χ2-test analysis was used to analyze the relationship between lncRNA DUXAP8 expression and clinicopathological information in patients with bladder cancer. The tumor cell activity and cell proliferation were measured by cell counting kit-8 (CCK8) and colony formation assay. We utilized polymerase chain reaction (PCR) to access PTEN expression in bladder cancer and adjacent tissues. Pearson correlation analysis was utilized for evaluating the relationship between PTEN and lncRNA DUXAP8. Western blot was used for detecting protein expression.
RESULTS: LncRNA DUXAP8 expression was higher in bladder cancer tissues; it was in a positive correlation with the TNM stage and tumor size, but negatively correlated with the total survival time. Knockdown of DUXAP8 decreased cell viability and cellular proliferation. Lower expression of PTEN gene was found in bladder cancer compared with that in adjacent tissues. Pearson correlation analysis showed that PTEN was negatively correlated with DUXAP8; knockdown of DUAP8 increased the expression of PTEN. Overexpressing DUAP8 increased protein level of PTEN, but decreased cell viability.
CONCLUSIONS: Our results pointed out that lncRNA DUXAP8 was overexpressed in bladder cancer tissues, which can promote the progression of bladder cancer through inhibiting PTEN.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29917188     DOI: 10.26355/eurrev_201806_15158

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  21 in total

Review 1.  Functions of lncRNA DUXAP8 in non-small cell lung cancer.

Authors:  Cui Wu; Wu Song; Zhongnan Wang; Bingmei Wang
Journal:  Mol Biol Rep       Date:  2022-01-15       Impact factor: 2.316

2.  The potential roles of lncRNAs DUXAP8, LINC00963, and FOXD2-AS1 in luminal breast cancer based on expression analysis and bioinformatic approaches.

Authors:  Maedeh Arabpour; Sepideh Mehrpour Layeghi; Javad Tavakkoly Bazzaz; Mohammad Mehdi Naghizadeh; Keivan Majidzadeh-A; Abbas Shakoori
Journal:  Hum Cell       Date:  2021-05-27       Impact factor: 4.174

3.  Long noncoding RNA DUXAP8 regulates proliferation and apoptosis of ovarian cancer cells via targeting miR-590-5p.

Authors:  Qingyou Meng; Zhongliang Li; Jiaxue Pan; Xiaorong Sun
Journal:  Hum Cell       Date:  2020-08-04       Impact factor: 4.174

4.  Long non‑coding RNA‑DUXAP8 regulates TOP2A in the growth and metastasis of osteosarcoma via microRNA‑635.

Authors:  Ting Yang; Jian Ping Guo; Fan Li; Chao Xiu; Hua Wang; Xian Liang Duan
Journal:  Mol Med Rep       Date:  2021-05-13       Impact factor: 2.952

5.  Long non-coding RNA DUXAP8 promotes tumorigenesis by regulating IGF1R via miR-9-3p in hepatocellular carcinoma.

Authors:  Qiang Guan; Bo Yuan; Xiaobin Zhang; Tinghai Yan; Jiangong Li; Wuzhong Xu
Journal:  Exp Ther Med       Date:  2021-05-12       Impact factor: 2.447

6.  LncRNA SOX2-OT regulates miR-192-5p/RAB2A axis and ERK pathway to promote glioblastoma cell growth.

Authors:  Hongcai Wang; Qinglei Hu; Yilei Tong; Shiwei Li; Maosong Chen; Boding Wang; Haimeng Li
Journal:  Cell Cycle       Date:  2021-09-01       Impact factor: 5.173

7.  Overexpressed pseudogenes, DUXAP8 and DUXAP9, promote growth of renal cell carcinoma and serve as unfavorable prognostic biomarkers.

Authors:  Jing Chen; Weiyang Lou; Bisha Ding; Xian Wang
Journal:  Aging (Albany NY)       Date:  2019-08-13       Impact factor: 5.682

8.  Long noncoding RNA DUXAP8 contributes to the progression of hepatocellular carcinoma via regulating miR-422a/PDK2 axis.

Authors:  Feifei Wei; Liang Yang; Dandan Jiang; Min Pan; Guiyan Tang; Mingyue Huang; Jing Zhang
Journal:  Cancer Med       Date:  2020-02-05       Impact factor: 4.452

9.  DUXAP8 a Pan-Cancer Prognostic Marker Involved in the Molecular Regulatory Mechanism in Hepatocellular Carcinoma: A Comprehensive Study Based on Data Mining, Bioinformatics, and in vitro Validation.

Authors:  Chaosen Yue; Chaojie Liang; Pengyang Li; Lijun Yan; Dongxin Zhang; Yingchen Xu; Zhigang Wei; Jixiang Wu
Journal:  Onco Targets Ther       Date:  2019-12-31       Impact factor: 4.147

10.  YY1-inudced activation of lncRNA DUXAP8 promotes proliferation and suppresses apoptosis of triple negative breast cancer cells through upregulating SAPCD2.

Authors:  Zhen Yang; Hongjian Ding; Zhiyu Pan; Huaqing Li; Junbin Ding; Qian Chen
Journal:  Cancer Biol Ther       Date:  2021-03-08       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.